SGER: Plasmapheresis After Partial Hepatectomy or Nephrectomy

SGER:部分肝切除术或肾切除术后的血浆置换术

基本信息

  • 批准号:
    9522534
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-06-15 至 1996-05-31
  • 项目状态:
    已结题

项目摘要

9522534 Simpson When one kidney or part of a kidney is surgically removed or becomes dysfunctional, the mass of the remaining kidney increases in a compensatory manner to maintain normal or near normal renal function. The processes that regulate the compensatory changes are not understood. In this proposal, Dr. Simpson puts forth the hypothesis that compensatory growth is the result of the inhibition of a organ-specific factor in the blood that normally suppresses tissue growth. Thus, when this factor is inhibited, specific tissues begin to proliferate. The growth is typified by an increased rate of cell division. He suggests that the suppressant material is produced by the organ (kidney in this case) itself to prevent over growth. Removal or loss of an organ reduces the plasma concentration of the suppressant and consequently permits cell growth. He will test this hypothesis by infusing plasma from a normal animal into one where two thirds of the kidney has been removed. This should prevent cell growth. Cell growth (division) will be tracked by DNA synthesis (incorporation of 3H-thymidine) 24 hours after the infusion of donor plasma. These experiments have the potential of providing valuable insights into normal and abnormal cell growth an regulation. ***
当一个肾脏或部分肾脏被手术切除或功能失调时,剩余肾脏的质量以代偿性方式增加,以维持正常或接近正常的肾功能。调节这种代偿性变化的过程尚不清楚。在这个提议中,辛普森博士提出了一个假设,即代偿性生长是血液中通常抑制组织生长的器官特异性因子受到抑制的结果。因此,当这个因子被抑制时,特定的组织开始增殖。生长的典型特征是细胞分裂率的增加。他认为,抑制物质是由器官(在这种情况下是肾脏)自身产生的,以防止过度生长。切除或失去一个器官会降低血浆中抑制剂的浓度,从而允许细胞生长。他将通过将一只正常动物的血浆注入一只已经切除三分之二肾脏的动物体内来验证这一假设。这应该可以防止细胞生长。在输注供体血浆24小时后,通过DNA合成(加入3h -胸腺嘧啶)跟踪细胞生长(分裂)。这些实验有可能为正常和异常细胞生长和调控提供有价值的见解。***

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Simpson其他文献

Measuring the Social Benefits of EPA Land Cleanup and Reuse Programs
衡量 EPA 土地清理和再利用计划的社会效益
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Robin R. Jenkins;E. Kopits;David Simpson
  • 通讯作者:
    David Simpson
EPIC: A Phase 3 Trial of Ponatinib Compared With Imatinib in CP-CML Patients
  • DOI:
    10.1016/j.clml.2015.04.076
  • 发表时间:
    2015-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jeffrey H. Lipton;Charles Chuah;Agnes Guerci-Bresler;Gianantonio Rosti;David Simpson;Stephanie Lustgarten;Victor M. Rivera;Tim Clackson;Frank G. Haluska;Michele Baccarani;Jorge E. Cortes;Francois Guilhot;Andreas Hochhaus;Timothy P. Hughes;Hagop Kantarjian;Neil P. Shah;Moshe Talpaz;Michael W. Deininger
  • 通讯作者:
    Michael W. Deininger
A Phase 1 Study with the Novel B-Cell Lymphoma 2 (Bcl-2) Inhibitor Bgb-11417 As Monotherapy or in Combination with Zanubrutinib (ZANU) in Patients (Pts) with CLL/SLL: Preliminary Data
一项使用新型 B 细胞淋巴瘤 2(Bcl-2)抑制剂 Bgb-11417 作为单药治疗或与 zanubrutinib(ZANU)联合治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)患者(pts)的 1 期研究:初步数据
  • DOI:
    10.1182/blood-2022-169662
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Chan Y. Cheah;Constantine S. Tam;Masa Lasica;Emma Verner;Peter J. Browett;Mary Ann Anderson;James Hilger;Yiqian Fang;David Simpson;Stephen Opat
  • 通讯作者:
    Stephen Opat
HIV-Associated Neuropathic Pain
  • DOI:
    10.2165/00023210-200519040-00005
  • 发表时间:
    2005-01-01
  • 期刊:
  • 影响因子:
    7.400
  • 作者:
    Susama Verma;Lydia Estanislao;David Simpson
  • 通讯作者:
    David Simpson
New products and industries from biodiversity
生物多样性带来的新产品和新产业
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Beattie;W. Barthlott;K. Kate;E. Elisabetsky;R. Farrel;Chua Teck Kheng;Iain Prance;J. Rosenthal;David Simpson;R. Leakey;M. Wolfson
  • 通讯作者:
    M. Wolfson

David Simpson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Simpson', 18)}}的其他基金

Application of microbial bioinformatics to investigate corneal infections
应用微生物生物信息学研究角膜感染
  • 批准号:
    NE/T014148/1
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Diversity in blood flow control to the brain: moving from individualized modelling towards personalized treatment of the injured brain
大脑血流控制的多样性:从个性化建模转向受伤大脑的个性化治疗
  • 批准号:
    EP/K036157/1
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Pan American Advanced Sciences Institute On Geophysical Research: New Tools and Techniques for Earthquake Hazard Analysis & Mitigation; Santo Domingo, Dominican Republic, July
泛美地球物理研究高级科学研究所:地震灾害分析的新工具和技术
  • 批准号:
    1242259
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Collaborative Research: Collection of Open Data for Broadband Seismological Observations of Aftershocks of the February 27, 2010 Chilean Earthquake
合作研究:2010 年 2 月 27 日智利地震余震宽带地震观测开放数据收集
  • 批准号:
    1036352
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
EAPSI: Cosmological Expansion and Collapse via Loop Quantum Gravity and Superstring Theory
EAPSI:通过环量子引力和超弦理论的宇宙膨胀和坍缩
  • 批准号:
    1015387
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Fellowship Award
The role of microRNAs in cell:cell communication
microRNA 在细胞间通讯中的作用
  • 批准号:
    BB/H005498/1
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Research Grant
MRI-Consortium: Development of a Greenland Ice Sheet Monitoring Network
MRI 联盟:格陵兰冰盖监测网络的开发
  • 批准号:
    0922983
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
New methods for assessing the control of blood flow in the brain
评估大脑血流控制的新方法
  • 批准号:
    EP/G010420/1
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Out of Africa: Geophysical Monitoring and Capacity Building around the World, Boston Massachusetts Workshop, February 18-19, 2008
走出非洲:世界各地的地球物理监测和能力建设,马萨诸塞州波士顿研讨会,2008 年 2 月 18-19 日
  • 批准号:
    0802867
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
A genetic system to study resistance to the soil-borne pathogen Verticillium dahliae in strawberry
研究草莓对土传病原体大丽黄萎病的抗性的遗传系统
  • 批准号:
    BB/E007074/1
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
    Research Grant

相似海外基金

Plasmapheresis as a Novel treatment of Postural Tachycardia Syndrome: a randomised controlled trial
血浆置换术作为体位性心动过速综合征的新型治疗方法:一项随机对照试验
  • 批准号:
    nhmrc : GNT1134261
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Postgraduate Scholarships
Plasmapheresis as a Novel treatment of Postural Tachycardia Syndrome: a randomised controlled trial
血浆置换术作为体位性心动过速综合征的新型治疗方法:一项随机对照试验
  • 批准号:
    nhmrc : 1134261
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Postgraduate Scholarships
Pathfinder: Determining the efficacy of plasmapheresis as a treatment for patients with chronic Pseudomonas infections and inhibitory antibodies
探路者:确定血浆置换术治疗慢性假单胞菌感染和抑制性抗体患者的疗效
  • 批准号:
    MR/N027027/1
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Research Grant
A nanosystem as an alternative to immunoadsorption plasmapheresis and its application in the treatment of dilated cardiomyopathy
替代免疫吸附血浆置换的纳米系统及其在扩张型心肌病治疗中的应用
  • 批准号:
    15K12531
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Elucidation of the mechanism of action for establishing novel strategies of plasmapheresis
阐明建立血浆置换新策略的作用机制
  • 批准号:
    22791086
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Tacrolimus and Plasmapheresis in Treatment-Resistant FSGS
他克莫司和血浆置换治疗难治性 FSGS
  • 批准号:
    7176978
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Tacrolimus and Plasmapheresis in Treatment-Resistant FSGS
他克莫司和血浆置换治疗难治性 FSGS
  • 批准号:
    7295745
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
PLASMAPHERESIS IN SERVERE LUPUS GLOMERULONEPHRITIS
严重狼疮性肾小球肾炎中的血浆去除术
  • 批准号:
    6244087
  • 财政年份:
    1997
  • 资助金额:
    --
  • 项目类别:
PREVENTION OF HYPERACUTE XENO GRAFT REJECTION BY REDUCTION OF NATURAL ANTIBODIES USING DOUBLE FILRATION PLASMAPHERESIS WITH EXVIVO XENOANTIBODY ABSORPTION AND BY INTRAVENOUS POLYCLONAL ANTIBODY AGAINST DONOR BLOOD CELLS INJECTION.
通过使用体外异抗体吸收的双过滤血浆置换法减少天然抗体以及静脉注射抗供体血细胞的多克隆抗体来预防超急性异种移植物排斥。
  • 批准号:
    05404045
  • 财政年份:
    1993
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
DISPOSABLE PLASMAPHERESIS DEVICE
一次性血浆去除装置
  • 批准号:
    2221677
  • 财政年份:
    1990
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了